Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionNomura Holdings Inc
Latest Disclosed Ownership4,200 shares
Latest Disclosed Value $ 553,308
Nomura Holdings Inc ownership in NBIX / Neurocrine Biosciences, Inc.

On May 15, 2026 - Nomura Holdings Inc filed a 13F-HR form disclosing ownership of 4,200 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $553,308 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 7,510 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -44.07% during the quarter.

Nomura Holdings Inc has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,200 -3,310 -44.07 553 -48.08 0.0015
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,510 -1,641 -17.93 1,065 -17.06 0.0014
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,151 4,542 98.55 1,285 121.76 0.0020
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,609 4,609 579 0.0010
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -13,434 -100.00 0 -100.00
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,434 13,434 1,834 0.0025
2025-01-13 2024-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 0 -1,700 -100.00 0 -100.00
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 0
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,700 1,700 234 0.0004
2023-02-15 2022-12-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 0 -9,000 -100.00 0 -100.00
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 0 -9,000 0
2022-11-15 2022-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 9,000 9,000 956 0.0039
2022-05-17 2022-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 0 -4,500 -100.00 0 -100.00
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 4,500 4,500 383 0.0010
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 0 -12,000 -100.00 0 -100.00
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 12,000 12,000 1 0.0026
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 0 -38,000 -100.00 0 -100.00
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 38,000 38,000 3,652 0.0080
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 0 -8,771 -100.00 0 -100.00
2020-05-15 2020-03-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 8,771 218 2.55 761 -17.19 0.0032
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 8,553 -21,947 -71.96 919 -66.29 0.0034
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 30,500 27,000 771.43 2,726 817.85 0.0104
2019-08-23 2019-06-30 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 3,500 -54,168 -93.93 297 -94.20 0.0013
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 3,500 -54,168 297
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 57,668 -7,998 -12.18 5,119 9.45 0.0216
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 65,666 9,479 16.87 4,677 -33.06 0.0174
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 56,187 17,148 43.93 6,987 82.19 0.0245
2018-08-17 2018-06-30 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 39,039 -2,243 -5.43 3,835 12.04 0.0122
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 39,039 -2,243 2,984
2018-05-14 2018-03-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 41,282 25,400 159.93 3,423 177.84 0.0059
2018-05-14 2018-03-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 57,164 4,655
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 15,882 -16,000 -50.19 1,232 -36.85 0.0022
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 31,882 21,750 214.67 1,951 318.67 0.0041
2017-08-15 2017-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 10,132 10,132 466 0.0011
2017-05-18 2017-03-31 13F/A-1 NEUROCRINE BIOSCIENCES CMN 64125C109 0 -9,031 -100.00 0 -100.00
2017-02-13 2016-12-31 13F NEUROCRINE BIOSCIENCES CMN 64125C109 9,031 -39 -0.43 350 -24.08 0.0009
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 9,070 9,070 -57.90 461 78.68 0.0013
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 0 -50,400 -100.00 0 -100.00
2013-08-15 2013-06-30 13F NEUROCRINE BIOSCIENCES CMN 64125C109 50,400 28,855 133.93 672 160.47 0.0055
2013-08-16 2013-03-31 13F/A-2 NEUROCRINE BIOSCIENCES CMN 64125C109 21,545 21,545 258 0.0027
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-01-13 2024-09-30 13F/A NEUROCRINE BIOSCIENCES COM Call 11,500 -31.55 1,325 -42.69 n/a n/a n/a
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Call 11,500 1,325 n/a n/a n/a
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Call 16,800 2,313 n/a n/a n/a
2023-02-15 2022-12-31 13F/A NEUROCRINE BIOSCIENCES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES CMN Call 0 0 n/a n/a n/a
2022-11-15 2022-09-30 13F NEUROCRINE BIOSCIENCES CMN Call 44,900 -49.89 4,771 -46.31 n/a n/a n/a
2022-08-17 2022-06-30 13F/A NEUROCRINE BIOSCIENCES CMN Call 89,600 40.44 8,886 45.74 n/a n/a n/a
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES CMN Call 89,600 8,886 n/a n/a n/a
2022-05-18 2022-03-31 13F NEUROCRINE BIOSCIENCES CMN Call 63,800 6,097 n/a n/a n/a
2020-11-12 2020-09-30 13F NEUROCRINE BIOSCIENCES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES CMN Call 80,000 9,768 n/a n/a n/a
2020-05-15 2020-03-31 13F/A NEUROCRINE BIOSCIENCES CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES CMN Call 30,000 50.00 3,224 89.76 n/a n/a n/a
2019-08-23 2019-06-30 13F/A NEUROCRINE BIOSCIENCES CMN Call 20,000 -33.33 1,699 n/a n/a n/a
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES CMN Call 20,000 1,699 n/a n/a n/a
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES CMN Call 30,000 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.